Severin Schwan, Roche CEO (Sebastien Bozon/AFP via Getty Images)

Up­dat­ed: Roche hits the brakes on Alzheimer's tri­als af­ter res­ur­rect­ed drug flunks PhI­II

Is it fi­nal­ly time for Roche to give up on gan­tenerum­ab?

The Swiss phar­ma gi­ant re­vealed that the an­ti-amy­loid drug has failed two Phase III …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.